Nouri Barkestani, Mahsa
Naserian, Sina
Khoddam, Fatemeh
Shamdani, Sara
Bambai, Bijan
Funding for this research was provided by:
SivanCell Company (SC_FR-010919)
Agence Nationale de la Recherche (ANR_15-RHUS60002)
la Fondation de la Maison de la Chimie (RAK20150LLA)
Article History
Received: 23 September 2021
Accepted: 12 April 2022
First Online: 6 May 2022
Competing interests
: Dr. Sina NASERIAN is the CEO of the CellMedEx Company. The rest of the authors declare that they have no competing interests.